GetTopicDetailResponse(id=cae48e725a7, topicName=藥物審批, introduction=藥物審批, content=null, image=null, comments=4, allHits=1023, url=https://h5.medsci.cn/topic?id=87725, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=16071, tagList=[TagDto(tagId=16071, tagName=藥物審批)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2037416, encodeId=283b203e41636, content=<a href='/topic/show?id=cae48e725a7' target=_blank style='color:#2F92EE;'>#藥物審批#</a>, objectTitle=美媒：過時藥物進入中國市場 藥物審批仍需改進, objectType=article, longId=66047, objectId=7ab16604ef7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ab16604ef7, replyNumber=0, likeNumber=78, createdTime=2016-08-01, rootId=0, userName=ms8435843352634314, userId=4b8c2500026, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ab16604ef7, moduleTitle=美媒：過時藥物進入中國市場 藥物審批仍需改進, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=7ab16604ef7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2037415, encodeId=4a16203e4154a, content=<a href='/topic/show?id=cae48e725a7' target=_blank style='color:#2F92EE;'>#藥物審批#</a>, objectTitle=FDA承諾加快對Boehringer肺部疾病藥物審批, objectType=article, longId=37481, objectId=cee73e48133, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cee73e48133, replyNumber=0, likeNumber=89, createdTime=2015-04-15, rootId=0, userName=ms8435843352634314, userId=4b8c2500026, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cee73e48133, moduleTitle=FDA承諾加快對Boehringer肺部疾病藥物審批, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=cee73e48133)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2037414, encodeId=3afd203e41498, content=<a href='/topic/show?id=cae48e725a7' target=_blank style='color:#2F92EE;'>#藥物審批#</a>, objectTitle=JAMA：FDA藥物審批標準彈性大, objectType=article, longId=29880, objectId=c5592988042, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5592988042, replyNumber=0, likeNumber=82, createdTime=2014-08-04, rootId=0, userName=ms8435843352634314, userId=4b8c2500026, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5592988042, moduleTitle=JAMA：FDA藥物審批標準彈性大, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=c5592988042)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2037413, encodeId=c6fd203e413b4, content=<a href='/topic/show?id=cae48e725a7' target=_blank style='color:#2F92EE;'>#藥物審批#</a>, objectTitle=2013年藥物審批：制藥業(yè)有理由樂觀嗎？, objectType=article, longId=29051, objectId=95ef29051eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=95ef29051eb, replyNumber=0, likeNumber=73, createdTime=2014-02-02, rootId=0, userName=ms8435843352634314, userId=4b8c2500026, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95ef29051eb, moduleTitle=2013年藥物審批：制藥業(yè)有理由樂觀嗎？, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=95ef29051eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
